The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/20187802

Download in:

View as

General Info

PMID
20187802